A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)

Clinical trial NCT07405151 · RECRUITING

Trial details

NCT number: NCT07405151
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Oesophageal Squamous Cell Carcinoma

Start date: 2026-03-27
Primary completion: 2027-06-12
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.